Comparing two creams with laser for focal vitiligo
Part of Skin clinical trials.
This trial tests two topical creams (one is a natural amino acid, the other is a chemotherapy-like drug) applied after a laser treatment to see which works better for restoring color in vitiligo patches. It may help if you have focal vitiligo and are otherwise healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of vitiligo called focal vitiligo, which means white patches appear in one or a few areas, not spread widely.
- You are not pregnant or breastfeeding.
- You do not have segmental vitiligo (a type that affects one side of the body).
- You do not have an autoimmune disease like thyroiditis or chronic conditions such as anemia, diabetes, or a weakened immune system.
- You do not have an active skin infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests three different techniques (two surgical methods and one laser) to treat non-vitiligo leukoderma, a condition where skin loses color in patches. It aims to see which method works best to restore color to affected areas.
This study tests a new way to treat vitiligo by combining a topical cream (methotrexate) with a special laser treatment (fractional CO2 laser) on similar patches on both sides of the body. It aims to see if this combination helps repigment the skin better.
This trial compares two procedures to improve white patches on the skin that are not caused by vitiligo: a fractional CO2 laser or a treatment called dermabrasion with 5-fluorouracil. Both aim to help skin color return to the affected areas.
This trial tests a new cream for vitiligo on the face or neck. It aims to see if the cream can help bring color back to white patches.
This trial tests a new medicine called TEV-53408 to see if it can help with vitiligo, a condition that causes white patches on the skin. It may help by restoring skin color, and the study will check how safe and effective it is.
This trial tests whether adding a daily nasal spray (Melanotan II) to light therapy helps restore color in stable vitiligo patches. It may be a good option for adults with mild to moderate nonsegmental vitiligo that hasn't changed in at least 6 months.
Hear when a new Focal Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.